CAS 100276-03-7 BAY R3401 - Analytical Products / Alfa Chemistry

CAT	AP100276037
CAS	100276-03-7
Structure
MDL Number	MFCD08705409
Molecular Weight	375.85
InChI Key	NPUSXSOBPNHOPH-UHFFFAOYSA-N

Description	≥98% (HPLC), solid
Solubility	DMSO: 15 mg/mL
Assay	≥98% (HPLC)
Color	white
Form	solid
Size	5MG, 25MG
Storage Conditions	2-8°C

1

Design, Synthesis, and Biological Application of Novel Photoaffinity Probes of Dihydropyridine Derivatives, BAY R3401

Liying Zhang, Zhiwei Yan, Youde Wang, Chengjun Song, Guangxin Miao

Molecules. 2019 Jun 28;24(13):2394.

PMID: 31261804

1

Effects of Insulin Deficiency or Excess on Hepatic Gluconeogenic Flux During Glycogenolytic Inhibition in the Conscious Dog

Dale S Edgerton, Sylvain Cardin, Catherine Pan, Doss Neal, Ben Farmer, Margaret Converse, Alan D Cherrington

Diabetes. 2002 Nov;51(11):3151-62.

PMID: 12401705

1

Molecular Mode of Inhibition of Glycogenolysis in Rat Liver by the Dihydropyridine Derivative, BAY R3401: Inhibition and Inactivation of Glycogen Phosphorylase by an Activated Metabolite

N Bergans, W Stalmans, S Goldmann, F Vanstapel

Diabetes. 2000 Sep;49(9):1419-26.

PMID: 10969824

1

Pancreatic Response to Mild Non-Insulin-Induced Hypoglycemia Does Not Involve Extrinsic Neural Input

S M Sherck, M Shiota, J Saccomando, S Cardin, E J Allen, J R Hastings, D W Neal, P E Williams, A D Cherrington

Diabetes. 2001 Nov;50(11):2487-96.

PMID: 11679426

1

Quantification of the Glycogen 13C-1 NMR Signal During Glycogen Synthesis in Perfused Rat Liver

N Bergans, T Dresselaers, L Vanhamme, P Van Hecke, S Van Huffel, F Vanstapel

NMR Biomed. 2003 Feb;16(1):36-46.

PMID: 12577296

* Products or Services Interested: BAY R3401 (100276-03-7)
* Your question
* Name
* Email
Verification Code